Publications in collaboration with researchers from Hospital Universitario de la Princesa (8)

2026

  1. Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

    Clinical and Translational Oncology, Vol. 28, Núm. 5, pp. 1807-1814

  2. Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)

    Clinical and Translational Oncology, Vol. 28, Núm. 1, pp. 320-329

  3. Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

    Clinical and Translational Oncology, Vol. 28, Núm. 6, pp. 2377-2385

2025

  1. Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

    Melanoma Research, Vol. 35, Núm. 6, pp. 399-408

2023

  1. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

    Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775

2017

  1. Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

    Medicine, Vol. 96, Núm. 52, pp. e9523

2016

  1. Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study

    Melanoma Research, Vol. 26, Núm. 3, pp. 278-283

2014

  1. Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

    Clinical Cancer Research, Vol. 20, Núm. 22, pp. 5697-5707